BlinkLab Brings First Clinical Site on Board for Autism Diagnostic Registrational Trial, Shares Rise 10%

MT Newswires Live

02/05

BlinkLab (ASX:BB1) said PriMED Clinical Research in Ohio became the first site to join the initial phase of the firm's US-based autism diagnostic registrational trial, according to a Wednesday Australian bourse filing.

The site is expected to commence patient recruitment and testing for the 100-patient study in February.

PriMED will use the overarching institutional review board approval BlinkLab secured for the clinical trial.

The firm is seeking to start initiating partnerships with sixteen sites across the US.

The firm's shares rose 10% in recent trading on Wednesday.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2509448073"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2509448073\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2509448073?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-02-05 09:51","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2509448073","market":"sh","top_or_hot":-1,"title":"BlinkLab Brings First Clinical Site on Board for Autism Diagnostic Registrational Trial, Shares Rise 10%","media":"MT Newswires Live","content":"<html><body><p> BlinkLab (ASX:BB1) said PriMED Clinical Research in Ohio became the first site to join the initial phase of the firm's US-based autism diagnostic registrational trial, according to a Wednesday Australian bourse filing.</p><p>The site is expected to commence patient recruitment and testing for the 100-patient study in February.</p><p>PriMED will use the overarching institutional review board approval BlinkLab secured for the clinical trial.</p><p>The firm is seeking to start initiating partnerships with sixteen sites across the US.</p><p>The firm's shares rose 10% in recent trading on Wednesday.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BlinkLab Brings First Clinical Site on Board for Autism Diagnostic Registrational Trial, Shares Rise 10%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBlinkLab Brings First Clinical Site on Board for Autism Diagnostic Registrational Trial, Shares Rise 10%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-02-05 09:51</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> BlinkLab (ASX:BB1) said PriMED Clinical Research in Ohio became the first site to join the initial phase of the firm's US-based autism diagnostic registrational trial, according to a Wednesday Australian bourse filing.</p><p>The site is expected to commence patient recruitment and testing for the 100-patient study in February.</p><p>PriMED will use the overarching institutional review board approval BlinkLab secured for the clinical trial.</p><p>The firm is seeking to start initiating partnerships with sixteen sites across the US.</p><p>The firm's shares rose 10% in recent trading on Wednesday.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BB1.AU","symbol_name":"Blinklab Ltd","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2509448073","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2509448073","pubTimestamp":1738720299,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"BlinkLab  said PriMED Clinical Research in Ohio became the first site to join the initial phase of the firm's US-based autism diagnostic registrational trial, according to a Wednesday Australian bourse filing.The site is expected to commence patient recruitment and testing for the 100-patient study in February.PriMED will use the overarching institutional review board approval BlinkLab secured for the clinical trial.The firm is seeking to start initiating partnerships with sixteen sites across the US.The firm's shares rose 10% in recent trading on Wednesday.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BB1.AU":"Blinklab Ltd","BK7094":"医疗保健技术"},"translate_title":"BlinkLab首个临床站点用于自闭症诊断注册试验，股价上涨10%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BB1.AU":0.9},"content_text":"BlinkLab (ASX:BB1) said PriMED Clinical Research in Ohio became the first site to join the initial phase of the firm's US-based autism diagnostic registrational trial, according to a Wednesday Australian bourse filing.The site is expected to commence patient recruitment and testing for the 100-patient study in February.PriMED will use the overarching institutional review board approval BlinkLab secured for the clinical trial.The firm is seeking to start initiating partnerships with sixteen sites across the US.The firm's shares rose 10% in recent trading on Wednesday.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}